These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

110 related items for PubMed ID: 3016270

  • 1. Analogues of 1,3-dipropyl-8-phenylxanthine: enhancement of selectivity at A1-adenosine receptors by aryl substituents.
    Daly JW, Padgett WL, Shamim MT.
    J Med Chem; 1986 Aug; 29(8):1520-4. PubMed ID: 3016270
    [Abstract] [Full Text] [Related]

  • 2. 1,3-Dialkyl-8-(p-sulfophenyl)xanthines: potent water-soluble antagonists for A1- and A2-adenosine receptors.
    Daly JW, Padgett W, Shamim MT, Butts-Lamb P, Waters J.
    J Med Chem; 1985 Apr; 28(4):487-92. PubMed ID: 2984420
    [Abstract] [Full Text] [Related]

  • 3. Mesoionic xanthine analogues: antagonists of adenosine receptors.
    Glennon RA, Tejani-Butt SM, Padgett W, Daly JW.
    J Med Chem; 1984 Oct; 27(10):1364-7. PubMed ID: 6090665
    [Abstract] [Full Text] [Related]

  • 4. Xanthine derivatives as antagonists at A1 and A2 adenosine receptors.
    Schwabe U, Ukena D, Lohse MJ.
    Naunyn Schmiedebergs Arch Pharmacol; 1985 Sep; 330(3):212-21. PubMed ID: 2997628
    [Abstract] [Full Text] [Related]

  • 5. 8-Aryl-and 8-cycloalkyl-1,3-dipropylxanthines: further potent and selective antagonists for A1-adenosine receptors.
    Shamim MT, Ukena D, Padgett WL, Hong O, Daly JW.
    J Med Chem; 1988 Mar; 31(3):613-7. PubMed ID: 3346878
    [Abstract] [Full Text] [Related]

  • 6. Analogues of caffeine and theophylline: effect of structural alterations on affinity at adenosine receptors.
    Daly JW, Padgett WL, Shamim MT.
    J Med Chem; 1986 Jul; 29(7):1305-8. PubMed ID: 3806581
    [Abstract] [Full Text] [Related]

  • 7. Structure-activity relationships of 8-styrylxanthines as A2-selective adenosine antagonists.
    Jacobson KA, Gallo-Rodriguez C, Melman N, Fischer B, Maillard M, van Bergen A, van Galen PJ, Karton Y.
    J Med Chem; 1993 May 14; 36(10):1333-42. PubMed ID: 8496902
    [Abstract] [Full Text] [Related]

  • 8. Potent adenosine receptor antagonists that are selective for the A1 receptor subtype.
    Martinson EA, Johnson RA, Wells JN.
    Mol Pharmacol; 1987 Mar 14; 31(3):247-52. PubMed ID: 3561384
    [Abstract] [Full Text] [Related]

  • 9. Sulfur-containing 1,3-dialkylxanthine derivatives as selective antagonists at A1-adenosine receptors.
    Jacobson KA, Kiriasis L, Barone S, Bradbury BJ, Kammula U, Campagne JM, Secunda S, Daly JW, Neumeyer JL, Pfleiderer W.
    J Med Chem; 1989 Aug 14; 32(8):1873-9. PubMed ID: 2754711
    [Abstract] [Full Text] [Related]

  • 10. Effects of 8-phenyl and 8-cycloalkyl substituents on the activity of mono-, di-, and trisubstituted alkylxanthines with substitution at the 1-, 3-, and 7-positions.
    Shamim MT, Ukena D, Padgett WL, Daly JW.
    J Med Chem; 1989 Jun 14; 32(6):1231-7. PubMed ID: 2724296
    [Abstract] [Full Text] [Related]

  • 11. Functionalized congeners of 1,3-dipropyl-8-phenylxanthine: potent antagonists for adenosine receptors that modulate membrane adenylate cyclase in pheochromocytoma cells, platelets and fat cells.
    Ukena D, Daly JW, Kirk KL, Jacobson KA.
    Life Sci; 1986 Mar 03; 38(9):797-807. PubMed ID: 3005794
    [Abstract] [Full Text] [Related]

  • 12. 8-Polycycloalkyl-1,3-dipropylxanthines as potent and selective antagonists for A1-adenosine receptors.
    Shimada J, Suzuki F, Nonaka H, Ishii A.
    J Med Chem; 1992 Mar 06; 35(5):924-30. PubMed ID: 1548682
    [Abstract] [Full Text] [Related]

  • 13. Adenosine receptor-blocking xanthines as inhibitors of phosphodiesterase isozymes.
    Ukena D, Schudt C, Sybrecht GW.
    Biochem Pharmacol; 1993 Feb 24; 45(4):847-51. PubMed ID: 7680859
    [Abstract] [Full Text] [Related]

  • 14. Species differences in structure-activity relationships of adenosine agonists and xanthine antagonists at brain A1 adenosine receptors.
    Ukena D, Jacobson KA, Padgett WL, Ayala C, Shamim MT, Kirk KL, Olsson RO, Daly JW.
    FEBS Lett; 1986 Dec 01; 209(1):122-8. PubMed ID: 3803571
    [Abstract] [Full Text] [Related]

  • 15. Xanthines with C8 chiral substituents as potent and selective adenosine A1 antagonists.
    Peet NP, Lentz NL, Dudley MW, Ogden AM, McCarty DR, Racke MM.
    J Med Chem; 1993 Dec 10; 36(25):4015-20. PubMed ID: 8258823
    [Abstract] [Full Text] [Related]

  • 16. [Selectivity of the action of 1,3-dipropyl-8-phenylxanthine on the purine receptors of the intestines].
    Gmiro VE, Komissarov IV, Serdiuk SE, Kharin NA.
    Farmakol Toksikol; 1988 Dec 10; 51(4):60-2. PubMed ID: 3191974
    [Abstract] [Full Text] [Related]

  • 17. 125I-labeled 8-phenylxanthine derivatives: antagonist radioligands for adenosine A1 receptors.
    Linden J, Patel A, Earl CQ, Craig RH, Daluge SM.
    J Med Chem; 1988 Apr 10; 31(4):745-51. PubMed ID: 3351850
    [Abstract] [Full Text] [Related]

  • 18. 8-Azaxanthine derivatives as antagonists of adenosine receptors.
    Franchetti P, Messini L, Cappellacci L, Grifantini M, Lucacchini A, Martini C, Senatore G.
    J Med Chem; 1994 Sep 02; 37(18):2970-5. PubMed ID: 8071944
    [Abstract] [Full Text] [Related]

  • 19. Electrophilic derivatives of purines as irreversible inhibitors of A1 adenosine receptors.
    Jacobson KA, Barone S, Kammula U, Stiles GL.
    J Med Chem; 1989 May 02; 32(5):1043-51. PubMed ID: 2709373
    [Abstract] [Full Text] [Related]

  • 20. 1,3,8- and 1,3,7-substituted xanthines: relative potency as adenosine receptor antagonists at the frog neuromuscular junction.
    Sebastião AM, Ribeiro JA.
    Br J Pharmacol; 1989 Jan 02; 96(1):211-9. PubMed ID: 2924073
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.